Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|April 16, 2019
CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large CohortMakbule Senel, Fatemeh Mojib-Yezdani, Ulrike Braisch, et al.
Frontiers in Immunology|November 7, 2022
Rheumatoid factor IgM autoantibodies control IgG homeostasisAntonella Nicolò, Timm Amendt, Omal El Ayoubi, et al.
Multiple Sclerosis and Related Disorders|January 24, 2020
Drug-induced liver injury associated with the biosimilar glatiramer acetate (Clift®)Sebastian Michels, Eugen Zizer, Thomas Fe Barth, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2015
Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter studyStefan Presslauer, Dejan Milosavljevic, Wolfgang Huebl, et al.
Neurobiology of Disease|August 5, 2026
Bi-compartmental CSF-serum analysis of NfL and GFAP differentiates central and peripheral pathology in neuroinfectious diseases: A monocentric real-world cohort studyDeborah K Erhart, Badrieh Fazeli, Franziska Bachhuber, et al.
Eclinicalmedicine|December 14, 2019
Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: A randomised, parallel-group, controlled trialJohannes Dorst, Tanja Fangerau, Daniela Taranu, et al.
European Neurology|March 5, 2011
Patterns of TH1/TH2 cytokines predict clinical response in multiple sclerosis patients treated with glatiramer acetateHayrettin Tumani, Jan Kassubek, Mohammed Hijazi, et al.
Frontiers in Neurology|July 3, 2023
Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases - a retrospective cross-sectional studyFelix Brauchle, Daniel Rapp, Makbule Senel, et al.
Biomedicines|August 28, 2025
Sensitivity and Specificity of a Revised Version of the TRACK-MS Screening Battery for Early Detection of Cognitive Impairment in Patients with Multiple SclerosisLuisa T Balz, Ingo Uttner, Daniela Taranu, et al.
Clinical Chemistry and Laboratory Medicine|February 14, 2024
Quantification of blood glial fibrillary acidic protein using a second-generation microfluidic assay. Validation and comparative analysis with two established assaysBadrieh Fazeli, Nerea Gómez de San José, Sarah Jesse, et al.
Pageof 7